Planet 13 Holdings (PLNH) Return on Capital Employed (2022 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Return on Capital Employed of 45.49% for Q1 2026, down 2412.0% year-over-year from 1.97% in Q1 2025, and down 1.47% quarter-over-quarter from 44.83% in Q4 2025.
Planet 13 Holdings (PLNH) Return on Capital Employed (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Return on Capital Employed for 5 consecutive years, with 45.49% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 2412.0% year-over-year to 45.49%; the TTM figure through Mar 2026 stood at 45.49% (down 2412.0% YoY), while the FY2025 annual figure was 37.92%, down 1484.0% from the prior year.
- Return on Capital Employed fell to 45.49% in Q1 2026 per PLNH's latest filing, from 44.83% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 2.91% in Q3 2022 and bottomed at 53.07% in Q3 2023.
- Historically, Return on Capital Employed has averaged 28.39% across 5 years, with a median of 24.36% in 2023.
- Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 5016 bps — and 2024, when it surged 4322 bps.
- Planet 13 Holdings' Return on Capital Employed stood at 21.54% in 2022, then tumbled by 100 bps to 43.14% in 2023, then soared by 59 bps to 17.8% in 2024, then sank by 152 bps to 44.83% in 2025, then decreased by 1 bps to 45.49% in 2026.
- Business Quant data shows PLNH's Return on Capital Employed at 45.49% in Q1 2026, 44.83% in Q4 2025, and 51.99% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Planet 13 Holdings | 54.56 Mn | 38.08 Mn | 12.32 Mn | -43.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -43.61% |
| Mar 31, 2026 | -45.49% |
| Dec 31, 2025 | -44.83% |
| Sep 30, 2025 | -51.99% |
| Jun 30, 2025 | -23.88% |
| Mar 31, 2025 | -21.37% |
| Dec 31, 2024 | -17.80% |
| Sep 30, 2024 | -9.85% |
| Jun 30, 2024 | -36.56% |
| Mar 31, 2024 | -43.64% |
| Dec 31, 2023 | -43.14% |
| Sep 30, 2023 | -53.07% |
| Jun 30, 2023 | -25.99% |
| Mar 31, 2023 | -24.36% |
| Dec 31, 2022 | -21.54% |
| Sep 30, 2022 | -2.91% |
| Jun 30, 2022 | -3.82% |
| Mar 31, 2022 | -12.46% |